Dr. David Warren, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 336 Factory Rd, Clinton, AR 72031 Phone: 501-745-2999 |
Sowers Chiropractic Clinic, Pa Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 116 Maxwell Street, Clinton, AR 72031 Phone: 501-745-2460 Fax: 501-745-4243 |
Timeless Family Chiropractic, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 116 Maxwell St., Clinton, AR 72031 Phone: 501-745-2460 |
Warren Chiropractic & Wellness Clinic, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 244 Highway 65 N Ste 1, Clinton, AR 72031 Phone: 501-745-2999 |
Jennifer Renee Beeson, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 116 Maxwell Street, Clinton, AR 72031 Phone: 501-253-0649 |
News Archive
Some adults see their mothers and fathers as still influencing their own health - but in very different ways, according to a new study.
Consumer groups in the U.S. are demanding that U.S. regulators postpone their final decision on Mentor Corp's silicone breast implants and are urging Congress to widen a related probe.
On February 11, 2005, the New York City Department of Health and Mental Hygiene (DOHMH) reported a case of HIV infection with a strain that is resistant to many drugs in three classes of HIV medications, and which appears to have progressed to AIDS within 4 to 20 months after infection.
Vertex Pharmaceuticals Incorporated today announced new data from its Phase 3 studies of people with genotype 1 chronic hepatitis C who have not been treated previously. In these studies, the majority of people achieved superior sustained viral response (SVR or viral cure) rates with a telaprevir-based combination regimen, compared to current therapies, regardless of race/ethnicity or stage of liver fibrosis (factors known to limit response to current hepatitis C treatments).
Aradigm Corporation today announced that it closed the transaction contemplated by the previously announced July 30, 2010 Stock Purchase Agreement with Novo Nordisk A/S. At the closing, the Company issued 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk A/S under which approximately $9.1 million was outstanding on July 30, 2010, representing an effective price per share of $0.3505.
› Verified 4 days ago